These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 26847678)
41. [Clinicopathologic features of pleomorphic rhabdomyosarcoma]. Yu L; Wang J Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):147-52. PubMed ID: 23769431 [TBL] [Abstract][Full Text] [Related]
42. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases]. Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593 [TBL] [Abstract][Full Text] [Related]
43. Prognostic factors in superficial adult soft tissue sarcomas: analysis of a series of 105 patients. Cany L; Stoeckle E; Coindre JM; Kantor G; Bonichon F; Bui BN J Surg Oncol; 1999 May; 71(1):4-9. PubMed ID: 10362084 [TBL] [Abstract][Full Text] [Related]
44. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas? Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752 [TBL] [Abstract][Full Text] [Related]
45. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS Cancer; 2003 May; 97(10):2544-53. PubMed ID: 12733154 [TBL] [Abstract][Full Text] [Related]
46. Undifferentiated pleomorphic sarcoma with co-existence of KRAS/PIK3CA mutations. Li B; Li L; Li X; Wang Y; Xie Y; Liu C; Li F Int J Clin Exp Pathol; 2015; 8(7):8563-7. PubMed ID: 26339434 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology. Ozcelik M; Seker M; Eraslan E; Koca S; Yazilitas D; Ercelep O; Ozaslan E; Kaya S; Hacibekiroglu I; Menekse S; Aksoy A; Taskoylu BY; Varol U; Arpaci E; Ciltas A; Oksuzoglu B; Zengin N; Gumus M; Aliustaoglu M Tumour Biol; 2016 Apr; 37(4):5231-7. PubMed ID: 26553363 [TBL] [Abstract][Full Text] [Related]
49. Head and neck soft tissue sarcomas: a multivariate analysis of outcomes. Bentz BG; Singh B; Woodruff J; Brennan M; Shah JP; Kraus D Ann Surg Oncol; 2004 Jun; 11(6):619-28. PubMed ID: 15172935 [TBL] [Abstract][Full Text] [Related]
50. Clinical importance of late recurrence in soft-tissue sarcomas. Gibbs JF; Lee RJ; Driscoll DL; McGrath BE; Mindell ER; Kraybill WG J Surg Oncol; 2000 Feb; 73(2):81-6. PubMed ID: 10694643 [TBL] [Abstract][Full Text] [Related]
51. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Gustafson P Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499 [TBL] [Abstract][Full Text] [Related]
52. Comparison of Features and Outcomes of Undifferentiated Pleomorphic Sarcoma of Bone and Soft Tissue. Gusho CA; Lee L; Guntin J; Blank AT J Surg Res; 2022 Feb; 270():313-320. PubMed ID: 34731728 [TBL] [Abstract][Full Text] [Related]
53. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas? Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499 [TBL] [Abstract][Full Text] [Related]
54. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance. Massi D; Beltrami G; Capanna R; Franchi A Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563 [TBL] [Abstract][Full Text] [Related]
55. Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group. Chbani L; Guillou L; Terrier P; Decouvelaere AV; Grégoire F; Terrier-Lacombe MJ; Ranchère D; Robin YM; Collin F; Fréneaux P; Coindre JM Am J Clin Pathol; 2009 Feb; 131(2):222-7. PubMed ID: 19141382 [TBL] [Abstract][Full Text] [Related]
56. Impact of margin status and local recurrence on soft-tissue sarcoma outcomes. Potter BK; Hwang PF; Forsberg JA; Hampton CB; Graybill JC; Peoples GE; Stojadinovic A J Bone Joint Surg Am; 2013 Oct; 95(20):e151. PubMed ID: 24132366 [TBL] [Abstract][Full Text] [Related]
58. Prospective evaluation of Ki-67 system in histological grading of soft tissue sarcomas in the Japan Clinical Oncology Group Study JCOG0304. Tanaka K; Hasegawa T; Nojima T; Oda Y; Mizusawa J; Fukuda H; Iwamoto Y World J Surg Oncol; 2016 Apr; 14():110. PubMed ID: 27091124 [TBL] [Abstract][Full Text] [Related]
59. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO). Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706 [TBL] [Abstract][Full Text] [Related]
60. The value of the high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma. Nakamura T; Matsumine A; Asanuma K; Matsubara T; Sudo A Bone Joint J; 2015 Jun; 97-B(6):847-52. PubMed ID: 26033068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]